STOCK TITAN

SIBANNAC, INC. CEO JOINS “NEW TO THE STREET” ANCHOR JANE KING IN INTERVIEW

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Sibannac, Inc. (OTC Pink: SNNC) announced that CEO David Mersky will be interviewed by Jane King on New to the Street. The discussion will focus on the company's entry into the alternative wellness sector. The interview is scheduled to air on Newsmax on February 20, 2022, at 10:00 AM EST and on Fox Business on February 21, 2022, at 10:30 PM PST.

Investors should consider that the statements made in the interview may include forward-looking statements subject to risks and uncertainties.

Positive
  • None.
Negative
  • None.

Scottsdale, Arizona, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following:

David Mersky, CEO of Sibannac, Inc., joins New to the Street anchor, Jane King, in an interview to discuss the Company’s entry into the alternative wellness space.

The interview will air on Newsmax on Sunday, February 20th at 10:00 AM EST and on Fox Business on Monday, February 21st at 10:30 PM PST.

Cautionary Note Regarding Forward-Looking Statements.

This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Sibannac, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.

Media Contact: IR@theCampusCo.com


FAQ

What is the significance of David Mersky's interview for Sibannac, Inc. (SNNC)?

David Mersky's interview highlights Sibannac's expansion into the alternative wellness space, which may attract investor interest.

When will the Sibannac, Inc. (SNNC) interview air on Newsmax?

The interview will air on Newsmax on February 20, 2022, at 10:00 AM EST.

What date will the Fox Business interview with Sibannac, Inc. (SNNC) be broadcast?

The Fox Business interview is scheduled for February 21, 2022, at 10:30 PM PST.

What should investors be cautious about regarding the statements made by Sibannac, Inc. (SNNC)?

Investors should be cautious as the interview may contain forward-looking statements that involve risks and uncertainties.

SIBANNAC INC

OTC:SNNC

SNNC Rankings

SNNC Latest News

SNNC Stock Data

3.51M
30.88M
20.13%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Phoenix